ORSOBIO, INC.
Profile
Company Names
ORSOBIO, INC.
Addresses
101 JEFFERSON DR 1ST FLOOR STE 124, MENLO PARK, CA 94025
2671 MARSHALL DRIVE, PALO ALTO, CA 94303
Phone Numbers
650-208-8348
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2020
State Incorporated:
DELAWARE
Total Amount Raised:
$124,629,383.00
Number of Funding Rounds:
2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2024-08-14
$40,000,000.00
$67,000,000.00
$27,000,000.00
Equity
1
2023-10-27
$84,629,383.00
$84,629,383.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
SRINIVAS
AKKARAJU
DIRECTOR
SEATTLE GENETICS INC /WA
| PRESIDIO PHARMACEUTICALS, INC.
| VERSARTIS, INC.
| PRINCIPIA BIOPHARMA INC.
| SYROS PHARMACEUTICALS, INC.
| SAMSARA BIOCAPITAL, L.P.
| 565 SPV I, L.P.
| TENTARIX BIOTHERAPEUTICS, LP
| CHINOOK THERAPEUTICS U.S., INC.
| MINERALYS THERAPEUTICS, INC.
| ORSOBIO, INC.
| VTV THERAPEUTICS INC.
| ALUMIS INC.
| SAMSARA OPPORTUNITY FUND, L.P.
CORY
FREEDLAND
DIRECTOR
GANGADHARA
GANAPATI
EXECUTIVE OFFICER, DIRECTOR
MUZAMMIL
MANSURI
DIRECTOR
EVAN
RACHLIN
DIRECTOR
ASCENTA CAPITAL SPV I, L.P.
| ASCENTA CAPITAL PROJECT TURING SPV, L.P.
| ASCENTA CAPITAL PROJECT ARGOS SPV, L.P.
| IAMBIC THERAPEUTICS, INC.
| ASCENTA CAPITAL FUND I, L.P.
| CARDURION PHARMACEUTICALS, INC.
| ASCENTA CAPITAL PROJECT IKIGAI SPV, L.P.
| ORSOBIO, INC.
| ASCENTA CAPITAL PROJECT HENRI SPV, L.P.
MATTHEW
YOUNG
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

